Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2018

Open Access 01-12-2018 | Research article

High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference

Authors: Hongyan Li, Daniel E. Furst, Hongtao Jin, Chao Sun, Xiaoping Wang, Lin Yang, Jingjing He, Yanru Wang, Aijing Liu

Published in: Arthritis Research & Therapy | Issue 1/2018

Login to get access

Abstract

Background

Thickened skin is a major clinical feature in patients with systemic sclerosis (SSc). We investigated changes of skin thickness in patients with SSc using both high frequency ultrasound (HFU) and the modified Rodnan skin score (mRSS) to evaluate the feasibility of application of HFU in skin involvement and the relationship between HFU and clinical profiles.

Methods

We recruited 31 consecutive patients with SSc and 31 age-matched and sex-matched healthy controls in this prospective, cross-sectional study. Skin thickness was measured by an 18-MHz ultrasonic probe at five different skin sites. Total skin thickness (TST) and skin thickness using categorical mRSS scores were recorded and compared to HFU. The European Scleroderma Trial and Research (EUSTAR) group Disease Activity Index (EUSTAR-DAI) and other clinical manifestations were assessed and analyzed.

Results

TST in patients with SSc was thicker than in healthy controls (P < 0.001), and correlated positively with total mRSS and the EUSTAR-DAI and correlated negatively with disease duration (P < 0.05). Patients with higher TST had higher EUSTAR-DAI, mRSS, C-reactive protein (CRP) and lower diffusing capacity of the lung for carbon monoxide (DLCO) (P < 0.05). Even in patients who on clinical assessment were assigned an mRSS that suggested the skin thickness was normal. This was also true to mRSS locally of 1 and 2 (P < 0.01). The area under the receiver operator characteristic (ROC) curve was 0.831 and yielded sensitivity of 77.4% and specificity of 87.1% at the predicted probability of 7.4 mm as the optimal cutoff point to access skin thickness.

Conclusions

In the study, HFU was able to measure skin thickness, it correlated quantitatively with a valid measure of SSc activity, and a minimal detectable difference was identified.
Appendix
Available only for authorised users
Literature
1.
go back to reference Varga J, Trajonowski M. Pathogenesis of systemic sclerosis: recent insights. J Scleroderma Relat Disord. 2017;2:137–52.CrossRef Varga J, Trajonowski M. Pathogenesis of systemic sclerosis: recent insights. J Scleroderma Relat Disord. 2017;2:137–52.CrossRef
2.
go back to reference van den Hoogen F, Khanna D, Fransen J, et al. 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47.CrossRefPubMedPubMedCentral van den Hoogen F, Khanna D, Fransen J, et al. 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47.CrossRefPubMedPubMedCentral
3.
go back to reference Hudson M, Fritzler MJ. Diagnostic criteria of systemic sclerosis. J Autoimmun. 2014;48–49:38–41.CrossRefPubMed Hudson M, Fritzler MJ. Diagnostic criteria of systemic sclerosis. J Autoimmun. 2014;48–49:38–41.CrossRefPubMed
4.
go back to reference Ionescu R, Rednic S, Damjanov N, et al. Repeated teaching courses of the modified Rodnan skin score in systemic sclerosis. Clin Exp Rheumatol. 2010;28(2 Suppl 58):S37–41.PubMed Ionescu R, Rednic S, Damjanov N, et al. Repeated teaching courses of the modified Rodnan skin score in systemic sclerosis. Clin Exp Rheumatol. 2010;28(2 Suppl 58):S37–41.PubMed
5.
go back to reference Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum. 2001;44:2828–35.CrossRefPubMed Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum. 2001;44:2828–35.CrossRefPubMed
6.
go back to reference Amjadi S, Maranian P, Furst D, et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum. 2009;60:2490–8.CrossRefPubMedPubMedCentral Amjadi S, Maranian P, Furst D, et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum. 2009;60:2490–8.CrossRefPubMedPubMedCentral
7.
go back to reference Khanna D, Furst DE, Clements PJ, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2:11–8.CrossRefPubMedPubMedCentral Khanna D, Furst DE, Clements PJ, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2:11–8.CrossRefPubMedPubMedCentral
8.
go back to reference Kaldas M, Khanna PP, Furst DE, et al. Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis–assessment of individual body sites in two large randomized controlled trials. Rheumatology (Oxford). 2009;48:1143–6.CrossRef Kaldas M, Khanna PP, Furst DE, et al. Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis–assessment of individual body sites in two large randomized controlled trials. Rheumatology (Oxford). 2009;48:1143–6.CrossRef
9.
go back to reference Jordan S, Distler JH, Maurer B, et al. Effects and safety of rituximab in systemic sclerosis: an analysis from the European scleroderma trial and research (EUSTAR) group. Ann Rheum Dis. 2015;74:1188–94.CrossRefPubMed Jordan S, Distler JH, Maurer B, et al. Effects and safety of rituximab in systemic sclerosis: an analysis from the European scleroderma trial and research (EUSTAR) group. Ann Rheum Dis. 2015;74:1188–94.CrossRefPubMed
10.
go back to reference Jung M, Bonner A, Hudson M, et al. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort. Scand J Rheumatol. 2014;43:217–20.CrossRefPubMed Jung M, Bonner A, Hudson M, et al. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort. Scand J Rheumatol. 2014;43:217–20.CrossRefPubMed
11.
go back to reference Porta F, Gargani L, Kaloudi O, et al. The new frontiers of ultrasound in the complex world of vasculitides and scleroderma. Rheumatology (Oxford). 2012;51(Suppl 7):vii26–30.CrossRef Porta F, Gargani L, Kaloudi O, et al. The new frontiers of ultrasound in the complex world of vasculitides and scleroderma. Rheumatology (Oxford). 2012;51(Suppl 7):vii26–30.CrossRef
12.
go back to reference Kaloudi O, Bandinelli F, Filippucci E, et al. High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis. 2010;69:1140–3.CrossRefPubMed Kaloudi O, Bandinelli F, Filippucci E, et al. High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis. 2010;69:1140–3.CrossRefPubMed
13.
go back to reference Elhai M, Guerini H, Bazeli R, et al. Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings. Arthritis Care Res (Hoboken). 2012;64:1244–9. Elhai M, Guerini H, Bazeli R, et al. Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings. Arthritis Care Res (Hoboken). 2012;64:1244–9.
14.
go back to reference Moore TL, Lunt M, Mc Manus B, et al. Seventeen-point dermal ultrasound scoring system–a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology (Oxford). 2003;42:1559–63.CrossRef Moore TL, Lunt M, Mc Manus B, et al. Seventeen-point dermal ultrasound scoring system–a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology (Oxford). 2003;42:1559–63.CrossRef
15.
go back to reference Sulli A, Ruaro B, Alessandri E, et al. Correlation between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients. Ann Rheum Dis. 2014;73:247–51.CrossRefPubMed Sulli A, Ruaro B, Alessandri E, et al. Correlation between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients. Ann Rheum Dis. 2014;73:247–51.CrossRefPubMed
16.
go back to reference Sedky MM, Fawzy SM, El Baki NA, et al. Systemic sclerosis: an ultrasonographic study of skin and subcutaneous tissue in relation to clinical findings. Skin Res Technol. 2013;19:e78–84.CrossRefPubMed Sedky MM, Fawzy SM, El Baki NA, et al. Systemic sclerosis: an ultrasonographic study of skin and subcutaneous tissue in relation to clinical findings. Skin Res Technol. 2013;19:e78–84.CrossRefPubMed
17.
go back to reference Ch’ng SS, Roddy J, Keen HI. A systematic review of ultrasonography as an outcome measure of skin involvement in systemic sclerosis. Int J Rheum Dis. 2013;16:264–72.CrossRefPubMed Ch’ng SS, Roddy J, Keen HI. A systematic review of ultrasonography as an outcome measure of skin involvement in systemic sclerosis. Int J Rheum Dis. 2013;16:264–72.CrossRefPubMed
18.
go back to reference van den Hoogen F, Khanna D, Fransen J, et al. 2013 Cassification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747–55.CrossRefPubMed van den Hoogen F, Khanna D, Fransen J, et al. 2013 Cassification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747–55.CrossRefPubMed
19.
20.
go back to reference Liu H, Hou Y, Zhu QL, et al. A preliminary study of skin ultrasound in diffuse cutaneous systemic sclerosis: does skin echogenicity matter? PLoS One. 2017;12:e0174481.CrossRefPubMedPubMedCentral Liu H, Hou Y, Zhu QL, et al. A preliminary study of skin ultrasound in diffuse cutaneous systemic sclerosis: does skin echogenicity matter? PLoS One. 2017;12:e0174481.CrossRefPubMedPubMedCentral
21.
go back to reference Akesson A, Hesselstrand R, Scheja A, et al. Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis. Ann Rheum Dis. 2004;63:791–6.CrossRefPubMedPubMedCentral Akesson A, Hesselstrand R, Scheja A, et al. Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis. Ann Rheum Dis. 2004;63:791–6.CrossRefPubMedPubMedCentral
22.
go back to reference Hesselstrand R, Carlestam J, Wildt M, et al. High frequency ultrasound of skin involvement in systemic sclerosis – a follow-up study. Arthritis Res Ther. 2015;17:329.CrossRefPubMedPubMedCentral Hesselstrand R, Carlestam J, Wildt M, et al. High frequency ultrasound of skin involvement in systemic sclerosis – a follow-up study. Arthritis Res Ther. 2015;17:329.CrossRefPubMedPubMedCentral
23.
go back to reference Valentini G, Iudici M, Walker UA, et al. The European scleroderma trials and research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis. 2017;76:270–6.CrossRefPubMed Valentini G, Iudici M, Walker UA, et al. The European scleroderma trials and research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis. 2017;76:270–6.CrossRefPubMed
24.
go back to reference Dobrota R, Maurer B, Graf N, et al. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Ann Rheum Dis. 2016;75:1743–8.CrossRefPubMedPubMedCentral Dobrota R, Maurer B, Graf N, et al. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Ann Rheum Dis. 2016;75:1743–8.CrossRefPubMedPubMedCentral
25.
go back to reference Czirják L, Nagy Z, Aringer M, et al. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis. 2007;66:966–9.CrossRefPubMedPubMedCentral Czirják L, Nagy Z, Aringer M, et al. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis. 2007;66:966–9.CrossRefPubMedPubMedCentral
26.
go back to reference Scheja A, Akesson A. Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma). Clin Exp Rheumatol. 1997;15:283–8.PubMed Scheja A, Akesson A. Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma). Clin Exp Rheumatol. 1997;15:283–8.PubMed
27.
go back to reference Sulli A, Ruaro B, Smith V, et al. Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. Arthritis Res Ther. 2017;19:61.CrossRefPubMedPubMedCentral Sulli A, Ruaro B, Smith V, et al. Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. Arthritis Res Ther. 2017;19:61.CrossRefPubMedPubMedCentral
28.
go back to reference Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol. 2010;6:578–87.CrossRefPubMed Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol. 2010;6:578–87.CrossRefPubMed
29.
go back to reference Hesselstrand R, Scheja A, Wildt M, et al. High frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease. Rheumatology (Oxford). 2008;47:84–7.CrossRef Hesselstrand R, Scheja A, Wildt M, et al. High frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease. Rheumatology (Oxford). 2008;47:84–7.CrossRef
30.
go back to reference Hou Y, Zhu QL, Liu H, et al. A preliminary study of acoustic radiation force impulse quantification for the assessment of skin in diffuse cutaneous systemic sclerosis. J Rheumatol. 2015;42:449–55.CrossRefPubMed Hou Y, Zhu QL, Liu H, et al. A preliminary study of acoustic radiation force impulse quantification for the assessment of skin in diffuse cutaneous systemic sclerosis. J Rheumatol. 2015;42:449–55.CrossRefPubMed
31.
go back to reference Furst DE, Clements PJ, Steen VD, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol. 1998;25:84–8.PubMed Furst DE, Clements PJ, Steen VD, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol. 1998;25:84–8.PubMed
Metadata
Title
High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference
Authors
Hongyan Li
Daniel E. Furst
Hongtao Jin
Chao Sun
Xiaoping Wang
Lin Yang
Jingjing He
Yanru Wang
Aijing Liu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2018
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-018-1686-9

Other articles of this Issue 1/2018

Arthritis Research & Therapy 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.